Group 1 - The core point of the article is that Giant Medical Holdings (02393.HK) anticipates a significant decline in its unaudited consolidated net profit for the six months ending June 30, 2025, dropping to no less than RMB 10 million from approximately RMB 1.093 billion for the six months ending June 30, 2024 [1] - As of August 15, 2025, Giant Medical Holdings' stock closed at HKD 0.17, down 2.3%, with a trading volume of 3.71 million shares and a transaction value of HKD 635,700 [1] - The investment banking community shows low interest in the stock, with no ratings provided in the past 90 days [1] Group 2 - Giant Medical Holdings has a market capitalization of HKD 406 million, ranking 21st in the specialized equipment industry [1] - Key financial metrics for Giant Medical Holdings compared to the industry average are as follows: - Return on Equity (ROE): -12.04% (industry average not provided) - Revenue: RMB 2.41 billion (industry average RMB 5.393 billion) - Net Profit Margin: 37.49% (industry average -10.1%) - Gross Profit Margin: 16.57% (industry average 23.25%) - Debt Ratio: 64.46% (industry average 49.84%) [1]
巨星医疗控股(02393.HK)发盈警 预计中期综合纯利将大幅减少至不少于1000万元